Nanjing Maternal and Child Care Hospital
Nanjing, Jiangsu, 210004, China
NCT Number: NCT00519246
With the incremental trend of benign breast tumor, the surgical process of mastectomy was proceeded too much every day, especially in the Maternal Health Care Hospital, but whether the investigators can find another way to relieve the postoperative pain after such an operation is still unknown. The investigators hypothesized that the pain from the relatively small surgery may not be significant compared to different treatments, even if no drug was delivered to them. The investigators are enrolling patients who underwent mastectomy from benign breast tumor, and are observing the analgesic effects of different drugs.
Looking for future studies?
Notify Me18 year–64 year
Female
Interventional
Phase 4
Nanjing, Jiangsu, 210004, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Saline 5 ml administrated intravenously
Other names: Physiological solution
Butorphanol tartrate 1 mg i.v.
Other names: NuoYang
Flurbiprofen Axetil 50 mg i.v.
Other names: CaiFen
Time frame: 0-24h after surgeries
Time frame: 0h to 24h after the end of the operation
Time frame: 24 h after operation
Time frame: From the initiation of analgesia (0 h) to the end of the study (24 h postoperative)
Nanjing Medical University
Other
Clinical Comparison of Postoperative Pain Therapeutic Effects After Benign Mastectomy
Acronym: COPTEAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06911892
Agnosia, Breast Cancer
Samsun, Ilkadim, Turkey (Türkiye)
View Trial DetailsNCT04343807
Agnosia, Anaesthesia
Karachi, Sindh, Pakistan
View Trial DetailsNCT04824183
Breast Cancer, Breast Diseases
Lilongwe, Malawi
View Trial DetailsNCT03125941
Breast Cancer, Breast Diseases
Copenhagen, Denmark
View Trial Details